Sichuan Kelun Pharmaceutical Co., Ltd. (SHE:002422)

Market Cap	49.55B
Revenue (ttm)	18.30B
Net Income (ttm)	1.67B
Shares Out	1.59B
EPS (ttm)	1.04
PE Ratio	29.90
Forward PE	25.04
Dividend	0.76 (2.45%)
Ex-Dividend Date	Oct 21, 2025

Volume	25,685,510
Average Volume	9,710,461
Open	32.00
Previous Close	31.99
Day's Range	30.99 - 32.10
52-Week Range	26.72 - 41.72
Beta	-0.04
RSI	31.79
Earnings Date	Apr 24, 2026

About SHE:002422

Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, produces, and sells infusion and non-infusion pharmaceutical products in China and internationally. It operates through Twinings, Botai, and Other Business segments. The company offers infusion products; oral medication and other dosage form; medical devices, such as infusion sets, sterile dispensing and injection syringes, vein detained needles, nebulizer sets, and vacuum blood collection tubes; over-the-counter products; and APIs to treat cardiovascular, IPF, ED, anti-tumor, anti-em...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1996
• Employees: 21,864
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002422

Financial Performance

In 2024, SHE:002422's revenue was 21.81 billion, an increase of 1.67% compared to the previous year's 21.45 billion. Earnings were 2.94 billion, an increase of 19.53%.